Second, this is the first reports to comprehensively compare peripheral metabolic profiles across CRS endotypes and healthy individuals, successfully identifying Cystatin-C as a novel and clinically accessible biomarker for differentiating eCRS from non-eCRS. Here, CST3 is linked to congenital rubella syndrome.